Thanks to the use of modern LifeFlow technology in the diagnosis of coronary heart disease, it is possible to increase patient comfort, reduce the number of complications by 15%* compared to classic diagnostic methods used in interventional cardiology and reduce a significant number of unnecessarily invasive diagnostic tests. This saves time and costs by 30% per year*. LifeFlow FFR CT CNBP technology is an improvement in diagnostic quality and accuracy based on an individual patient model, enabling more effective detection of coronary artery disease in approx. 20-30% of patients**

* Projected Costs and Consequences of Computed Tomography-Determined Fractional Flow Reserve, Clin. Cardiol. 36, 12, 743–748 (2013), Mark A. Hlatky, MD; Akshay Saxena, MD; Bon-Kwon Koo, MD; Andrejs Erglis, MD; Christopher K. Zarins, MD; James K. Min, MD

** Arbab-Zadeh, Heart Int 2012. Yokota, et al. Neth Heart J 2018. Nakanishi, et al. J Nucl Cardiol 2018.